| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Institut National de la Santé et de la Recherche Médicale (Inserm), Unit 689 (S.T., O.H., H.A.O., V.B., R.M., B.E., A.T., Z.M.), Centre de Recherche Cardiovasculaire Lariboisière, U589 (P.G.), Toulouse, and Unit U755 (K.C.), Paris, France; Atherosclerosis and Metabolism Unit (W.V., P.H.), Katholieke Universiteit Leuven, Leuven, Belgium; and Université Pierre et Marie Curie-Paris 6 (K.C.), Paris, France.
Correspondence to Ziad Mallat, MD, PhD, Institut National de la Sante et de la Recherche Medicale (Inserm), U689, 41 Bd de la Chapelle, Paris, France 75010. E-mail mallat{at}larib.inserm.fr
Objective— Obesity is a major risk factor for atherosclerosis and is associated with increased cardiovascular morbidity and mortality. However, the precise molecular pathways responsible for this close association remain poorly understood.
Methods and Results— In this study, we report that leptin-deficiency (ob/ob) in low-density lipoprotein receptor knockout (ldlr–/–) mice induces an unexpected 2.2- to 6-fold reduction in atherosclerotic lesion development, compared with ldlr–/– mice having similar total cholesterol levels. Ldlr–/–/ob/ob mice show reduced T cell helper type 1 (Th1) response, enhanced expression of Foxp3, the specification transcription factor of regulatory T (Treg) cells, and improved Treg cell function. Leptin receptor-deficient (db/db) mice display marked increase in the number and suppressive function of Treg cells. Supplementation of Treg-deficient lymphocytes with Treg cells from db/db mice in an experimental model of atherosclerosis induces a significant reduction of lesion size and a marked inhibition of interferon (INF)-
production, compared with supplementation by Treg cells from wild-type mice.
Conclusions— These results identify a critical role for leptin/leptin receptor pathway in the modulation of the regulatory immune response in atherosclerosis, and suggest that alteration in regulatory immunity may predispose obese individuals to atherosclerosis.
Leptin, a hormone that increases with obesity, was suggested to either accelerate or protect from atherosclerosis. Here, we identify a critical role for leptin/leptin receptor pathway in the modulation of the regulatory immune response in atherosclerosis, and suggest that alteration in regulatory immunity may predispose obese individuals to atherosclerosis.
Key Words: leptin obesity metabolic syndrome atherosclerosis immunity
Related Article:
Arterioscler. Thromb. Vasc. Biol. 2007 27: 2493-2495.
This article has been cited by other articles:
![]() |
L Mascitelli, F Pezzetta, and M R Goldstein Leptin and regulatory T cells in obese patients with asthma Thorax, July 1, 2008; 63(7): 659 - 659. [Full Text] [PDF] |
||||
![]() |
M. Thewissen and J. W. Cohen Tervaert Leptin and ANCA-associated vasculitis: a healthy link? Rheumatology, April 1, 2008; 47(4): 387 - 389. [Full Text] [PDF] |
||||
![]() |
B. K. Surmi, R. D. Atkinson, M. L. Gruen, K. R. Coenen, and A. H. Hasty The role of macrophage leptin receptor in aortic root lesion formation Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E488 - E495. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |